- Report
- November 2023
- 30 Pages
Global
From €2440EUR$2,750USD£2,087GBP
- Report
- November 2023
- 30 Pages
Global
From €2440EUR$2,750USD£2,087GBP
- Report
- November 2023
- 30 Pages
Global
From €2440EUR$2,750USD£2,087GBP
- Report
- February 2024
- 117 Pages
Global
From €4214EUR$4,750USD£3,605GBP
- Report
- June 2025
- 400 Pages
Global
From €4391EUR$4,949USD£3,756GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2474EUR$2,789USD£2,116GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2474EUR$2,789USD£2,116GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3433EUR$3,869USD£2,936GBP
- Report
- August 2024
- 168 Pages
Global
From €2218EUR$2,500USD£1,897GBP
- Report
- October 2023
- 38 Pages
Global
From €3544EUR$3,995USD£3,032GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €7980EUR$8,995USD£6,826GBP
- Report
- July 2025
- 209 Pages
Global
From €4431EUR$4,995USD£3,790GBP
- Report
- July 2025
- 210 Pages
Global
From €4431EUR$4,995USD£3,790GBP
- Report
- January 2025
- 182 Pages
Global
From €4431EUR$4,995USD£3,790GBP
- Report
- August 2025
- 150 Pages
Global
From €2733EUR$3,080USD£2,337GBP
€3416EUR$3,850USD£2,922GBP
- Report
- May 2024
- 130 Pages
Global
From €3504EUR$3,950USD£2,997GBP
- Report
- February 2026
- 173 Pages
Canada
From €4303EUR$4,850USD£3,680GBP
- Report
- February 2026
- 182 Pages
China
From €4303EUR$4,850USD£3,680GBP
- Report
- February 2026
- 174 Pages
Germany
From €4303EUR$4,850USD£3,680GBP
- Report
- February 2026
- 175 Pages
India
From €4303EUR$4,850USD£3,680GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more